{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:53:05Z","timestamp":1788310385828,"version":"build-2803163510"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1213\/ane.0b013e3181adca28","type":"journal-article","created":{"date-parts":[[2009,9,16]],"date-time":"2009-09-16T03:16:20Z","timestamp":1253070980000},"page":"1049-1053","source":"Crossref","is-referenced-by-count":60,"title":["Malignant Hyperthermia, Coexisting Disorders, and Enzymopathies: Risks and Management Options"],"prefix":"10.1213","volume":"109","author":[{"given":"Joan","family":"Benca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirk","family":"Hogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-11-20210902","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.2106\/00004623-200110000-00006","article-title":"Spinal deformities in Noonan syndrome: a clinical review of sixty cases.","volume":"83-A","author":"Lee","year":"2001","journal-title":"J Bone Joint Surg"},{"key":"R2-11-20210902","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0022-3476(75)80974-7","article-title":"An evaluation of the possible association of malignant hyperpyrexia with the Noonan syndrome using serum creatine phosphokinase levels.","volume":"86","author":"Hunter","year":"1975","journal-title":"J Pediatr"},{"key":"R3-11-20210902","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1093\/bja\/56.12.1443","article-title":"Occurrence of malignant hyperpyrexia in a patient with osteogenesis imperfecta.","volume":"56","author":"Rampton","year":"1984","journal-title":"Br J Anaesth"},{"key":"R4-11-20210902","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/j.1365-2044.1996.tb12619.x","article-title":"Osteogenesis imperfecta and malignant hyperthermia: is there a relationship?","volume":"51","author":"Porsborg","year":"1996","journal-title":"Anaesthesia"},{"key":"R5-11-20210902","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1542\/peds.49.3.375","article-title":"Physiological evidence of hypermetabolism in osteogenesis imperfecta.","volume":"49","author":"Cropp","year":"1972","journal-title":"Pediatrics"},{"key":"R6-11-20210902","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1213\/00000539-198906000-00025","article-title":"Osteogenesis imperfecta and hyperthermia.","volume":"68","author":"Ryan","year":"1989","journal-title":"Anesth Analg"},{"key":"R7-11-20210902","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/BF00439417","article-title":"Metabolic acidosis in osteogenesis imperfecta.","volume":"145","author":"Sadat","year":"1986","journal-title":"Eur J Pediatr"},{"key":"R8-11-20210902","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/j.1460-9592.1995.tb00340.x","article-title":"Letter: Malignant hyperthermia susceptibility in patients with osteogenesis imperfecta.","volume":"5","author":"Peluso","year":"1995","journal-title":"Paediatr Anaesth"},{"key":"R9-11-20210902","first-page":"261","article-title":"Increased postoperative febrile response in children with osteogenesis imperfecta.","volume":"23","author":"Ghert","year":"2003","journal-title":""},{"key":"R10-11-20210902","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/bja\/60.3.268","article-title":"Clinical presentation of malignant hyperthermia.","volume":"60","author":"Rosenberg","year":"1988","journal-title":"Br J Anaesth"},{"key":"R11-11-20210902","first-page":"1000","article-title":"End tidal CO2 monitoring. Its use in the diagnosis and management of malignant hyperthermia.","volume":"39","author":"Baudendistel","year":"1984","journal-title":""},{"key":"R12-11-20210902","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1365-2044.1991.tb09548.x","article-title":"Hypermetabolism in arthrogryposis multiplex congenita.","volume":"46","author":"Hopkins","year":"1991","journal-title":"Anaesthesia"},{"key":"R13-11-20210902","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1177\/0310057X8601400408","article-title":"Anaesthesia for patients with arthrogryposis multiplex congenital: what is the risk of malignant hyperthermia?","volume":"14","author":"Baines","year":"1986","journal-title":"Anaesth Intensive Care"},{"key":"R14-11-20210902","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0022-3476(73)80309-9","article-title":"Anaesthetic-induced malignant hyperpyrexia in children.","volume":"83","author":"King","year":"1973","journal-title":"J Paediatr"},{"key":"R15-11-20210902","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/mus.880150619","article-title":"Dominantly inherited malignant hyperthermia (MH) in the King-Denborough syndrome.","volume":"15","author":"Isaacs","year":"1992","journal-title":"Muscle Nerve"},{"key":"R16-11-20210902","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1212\/01.wnl.0000324929.33780.2f","article-title":"King-Denborough syndrome caused by a novel mutation in the ryanodine receptor gene.","volume":"71","author":"D\u2019Arcy","year":"2008","journal-title":"Neurology"},{"key":"R17-11-20210902","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1006\/mgme.2000.3009","article-title":"A variable myopathy associated with heterozygosity for the R503C mutation in the carnitine palmitoyltransferase II gene.","volume":"70","author":"Vladutiu","year":"2000","journal-title":"Mol Genet Metab"},{"key":"R18-11-20210902","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/mus.880160509","article-title":"Carnitine palmitoyl transferase deficiency in malignant hyperthermia.","volume":"16","author":"Vladutiu","year":"1993","journal-title":"Muscle Nerve"},{"key":"R18A-11-20210902","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1213\/ane.0b013e3181ad63b4","article-title":"Malignant hyperthermia-like syndrome and carnitine palmitoyltransferase II deficiency with heterozygous R503C mutation.","volume":"109","author":"Hogan","year":"2009","journal-title":"Anesth Analg"},{"key":"R19-11-20210902","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1097\/00000542-198806000-00021","article-title":"Postanesthetic acute renal failure due to carnitine palmityl transferase deficiency.","volume":"68","author":"Katsuya","year":"1988","journal-title":"Anesthesiology"},{"key":"R20-11-20210902","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/bja\/49.5.495","article-title":"Rhabdomyolysis induced by anaesthesia with intraoperative cardiac arrest.","volume":"49","author":"Schaer","year":"1977","journal-title":"Br J Anaesth"},{"key":"R21-11-20210902","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0006-3495(93)81101-9","article-title":"Activation of the Ca2+ release channel of skeletal muscle sarcoplasmic reticulum by palmitoyl carnitine.","volume":"65","author":"El-Hayek","year":"1993","journal-title":"Biophys J"},{"key":"R22-11-20210902","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/mus.880120307","article-title":"Myophosphorylase B deficiency and malignant hyperthermia.","volume":"12","author":"Isaacs","year":"1989","journal-title":"Muscle Nerve"},{"key":"R23-11-20210902","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1111\/j.1399-6576.2005.00755.x","article-title":"McArdle\u2019s disease and anaesthesia: case reports. Review of potential problems and association with malignant hyperthermia.","volume":"49","author":"Bollig","year":"2005","journal-title":"Acta Anaesthesiol Scand"},{"key":"R24-11-20210902","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.nmd.2006.12.014","article-title":"Molecular characterization of myophosphorylase deficiency (McArdle disease) in 34 patients from Southern France: identification of 10 new mutations. Absence of genotype-phenotype correlation.","volume":"17","author":"Aquaron","year":"2007","journal-title":"Neuromuscul Disord"},{"key":"R25-11-20210902","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/s00415-008-0530-6","article-title":"AMP deaminase deficiency in skeletal muscle is unlikely to be of clinical relevance.","volume":"255","author":"Hanish","year":"2008","journal-title":"J Neurol"},{"key":"R26-11-20210902","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/0006-2944(85)90097-3","article-title":"Myoadenylate deaminase deficiency and malignant hyperthermia susceptibility: is there a relationship?","volume":"34","author":"Fishbein","year":"1985","journal-title":"Biochem Med"},{"key":"R27-11-20210902","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1097\/00000542-200212000-00044","article-title":"Positive malignant hyperthermia susceptibility in vitro test in a patient with mitochondrial myopathy and myoadenylate deaminase deficiency.","volume":"97","author":"Fricker","year":"2002","journal-title":"Anesthesiology"},{"key":"R28-11-20210902","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/sj.ejhg.5201200","article-title":"Autosomal dominant Brody disease cosegregates with a chromosomal (2;7) (p11.2;p12.1) translocation in an Italian family.","volume":"12","author":"Novelli","year":"2004","journal-title":"Eur J Hum Genet"},{"key":"R29-11-20210902","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/ana.410200108","article-title":"Myopathy caused by a deficiency of Ca2+-adenosine triphosphatase in sarcoplasmic reticulum (Brody\u2019s disease).","volume":"20","author":"Karpati","year":"1986","journal-title":"Ann Neurol"},{"key":"R30-11-20210902","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1471-2253-5-8","article-title":"Inhibition of sarcoplasmic Ca-ATPase increases caffeine- and halothane-induced contractures in muscle bundles of malignant hyperthermia susceptible and healthy individuals.","volume":"5","author":"Schuster","year":"2005","journal-title":"BMC Anesthesiol"},{"key":"R31-11-20210902","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1213\/00000539-199105000-00022","article-title":"Unexplained increases in serum creatine kinase levels: its relation to MH susceptibility.","volume":"72","author":"Lingaraju","year":"1991","journal-title":"Anesth Analg"},{"key":"R32-11-20210902","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1213\/00000539-199705000-00016","article-title":"Malignant hyperthermia testing in patients with persistently increased serum creatine kinase levels.","volume":"84","author":"Weglinski","year":"1997","journal-title":"Anesth Analg"},{"key":"R33-11-20210902","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/ALN.0b013e3181862a0d","article-title":"Muscle biopsy and in vitro contracture test in subjects with idiopathic hyperCKemia.","volume":"109","author":"Malandrini","year":"2008","journal-title":"Anesthesiology"}],"container-title":["Anesthesia & Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1213\/ane.0b013e3181adca28","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:12:57Z","timestamp":1786111977000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000539-200910000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0b013e3181adca28","relation":{},"ISSN":["0003-2999"],"issn-type":[{"value":"0003-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}